Penumbra Revenue 2014-2025 | PEN

Penumbra annual/quarterly revenue history and growth rate from 2014 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Penumbra revenue for the quarter ending March 31, 2025 was $0.324B, a 16.32% increase year-over-year.
  • Penumbra revenue for the twelve months ending March 31, 2025 was $1.240B, a 13.17% increase year-over-year.
  • Penumbra annual revenue for 2024 was $1.195B, a 12.86% increase from 2023.
  • Penumbra annual revenue for 2023 was $1.059B, a 24.95% increase from 2022.
  • Penumbra annual revenue for 2022 was $0.847B, a 13.32% increase from 2021.
Penumbra Annual Revenue
(Millions of US $)
2024 $1,195
2023 $1,059
2022 $847
2021 $748
2020 $560
2019 $547
2018 $445
2017 $334
2016 $263
2015 $186
2014 $126
2013 $89
Penumbra Quarterly Revenue
(Millions of US $)
2025-03-31 $324
2024-12-31 $316
2024-09-30 $301
2024-06-30 $299
2024-03-31 $279
2023-12-31 $285
2023-09-30 $271
2023-06-30 $261
2023-03-31 $241
2022-12-31 $221
2022-09-30 $214
2022-06-30 $208
2022-03-31 $204
2021-12-31 $204
2021-09-30 $190
2021-06-30 $184
2021-03-31 $169
2020-12-31 $167
2020-09-30 $151
2020-06-30 $105
2020-03-31 $137
2019-12-31 $145
2019-09-30 $140
2019-06-30 $134
2019-03-31 $128
2018-12-31 $121
2018-09-30 $112
2018-06-30 $110
2018-03-31 $103
2017-12-31 $96
2017-09-30 $84
2017-06-30 $81
2017-03-31 $73
2016-12-31 $73
2016-09-30 $67
2016-06-30 $65
2016-03-31 $58
2015-12-31 $54
2015-09-30 $50
2015-06-30 $42
2015-03-31 $39
2014-12-31
2014-09-30 $32
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $9.027B $1.195B
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $180.563B 21.85
Intuitive Surgical (ISRG) United States $177.754B 73.68
Edwards Lifesciences (EW) United States $46.928B 31.13
IDEXX Laboratories (IDXX) United States $45.454B 52.24
Alcon (ALC) Switzerland $45.309B 30.62
DexCom (DXCM) United States $34.894B 53.93
IQVIA Holdings (IQV) United States $33.859B 19.13
Mettler-Toledo (MTD) United States $26.269B 31.24
STERIS (STE) Ireland $22.671B 24.97
Waters (WAT) United States $18.028B 25.44
SONOVA HOLDING (SONVY) Switzerland $17.531B 0.00
Hologic (HOLX) United States $14.819B 16.10
Sysmex ADR (SSMXY) Japan $10.682B 30.30
Masimo (MASI) United States $8.926B 32.92
Globus Medical (GMED) United States $7.375B 17.57
Glaukos (GKOS) United States $5.388B 0.00
Teleflex (TFX) United States $5.179B 8.55
Integer Holdings (ITGR) United States $3.786B 18.97
TransMedics (TMDX) United States $3.657B 79.50
PROCEPT BioRobotics (PRCT) United States $3.083B 0.00
LivaNova (LIVN) United Kingdom $2.381B 14.18
Nihon Kohden (NHNKY) Japan $2.144B 24.59
Elekta AB (EKTAY) Sweden $1.991B 17.90
Veracyte (VCYT) United States $1.977B 27.75
Alphatec Holdings (ATEC) United States $1.582B 0.00
Artivion (AORT) United States $1.341B 125.60
OPKO Health (OPK) United States $1.086B 0.00
Tandem Diabetes Care (TNDM) United States $1.058B 0.00
Integra LifeSciences Holdings (IART) United States $1.019B 5.42
Pulse Biosciences (PLSE) United States $1.004B 0.00
SiBone (SIBN) United States $0.735B 0.00
IRadimed (IRMD) United States $0.716B 36.33
Beta Bionics (BBNX) United States $0.643B 0.00
AxoGen (AXGN) United States $0.609B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.555B 8.64
OrthoPediatrics (KIDS) United States $0.553B 0.00
Semler Scientific (SMLR) United States $0.525B 11.30
Pacific Biosciences Of California (PACB) United States $0.462B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.442B 0.00
Mesa Laboratories (MLAB) United States $0.416B 9.67
Delcath Systems (DCTH) United States $0.397B 0.00
AngioDynamics (ANGO) United States $0.375B 0.00
Treace Medical Concepts (TMCI) United States $0.358B 0.00
RxSight (RXST) United States $0.324B 0.00
ClearPoint Neuro (CLPT) United States $0.314B 0.00
Neuronetics (STIM) United States $0.297B 0.00
NeuroPace (NPCE) United States $0.295B 0.00
908 Devices (MASS) United States $0.266B 0.00
Alpha Tau Medical (DRTS) Israel $0.260B 0.00
Tactile Systems Technology (TCMD) United States $0.245B 14.86
CVRx (CVRX) United States $0.217B 0.00
Monogram Orthopaedics (MGRM) United States $0.203B 0.00
Inogen (INGN) United States $0.183B 0.00
Sight Sciences (SGHT) United States $0.180B 0.00
Rapid Micro Biosystems (RPID) United States $0.179B 0.00
Spectral Diagnostics (EDTXF) Canada $0.174B 0.00
LENSAR (LNSR) United States $0.154B 0.00
Accuray (ARAY) United States $0.140B 0.00
Biosig Technologies (BSGM) United States $0.131B 0.00
Lucid Diagnostics (LUCD) United States $0.120B 0.00
Anteris Technologies Global (AVR) Australia $0.117B 0.00
Atossa Genetics (ATOS) United States $0.108B 0.00
Microbot Medical (MBOT) United States $0.108B 0.00
Sensus Healthcare (SRTS) United States $0.091B 55.10
EnVVeno Medical (NVNO) United States $0.087B 0.00
Hyperfine (HYPR) United States $0.084B 0.00
InspireMD (NSPR) United States $0.074B 0.00
Vicarious Surgical (RBOT) United States $0.067B 0.00
Spectral AI (MDAI) United States $0.066B 0.00
QT Imaging Holdings (QTIH) United States $0.053B 0.00
Covalon Technologies (CVALF) Canada $0.053B 21.44
EDAP TMS S.A (EDAP) France $0.052B 0.00
Positron (POSC) United States $0.051B 0.00
WORK Medical Technology Group (WOK) China $0.047B 0.00
Precision Optics (POCI) United States $0.037B 0.00
Envoy Medical (COCH) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.029B 0.00
Adagio Medical Holdings (ADGM) United States $0.026B 0.00
NexGel (NXGL) United States $0.018B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.018B 0.00
Baird Medical Investment Holdings (BDMD) $0.013B 0.00
Ekso Bionics Holdings (EKSO) United States $0.011B 0.00
PAVmed (PAVM) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
ReShape Lifesciences (RSLS) United States $0.006B 0.00
ENDRA Life Sciences (NDRA) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 15.10